SCHEMBL7940276

SCHEMBL7940276

COC/C=C/c1cncc(-c2cc3ccccc3n2C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB1 P11230 1/20 0.48
CHRNB2 P17787 1/20 0.48
CHRNB4 P30926 1/20 0.48
CHRNA3 P32297 1/20 0.48
CHRNB3 Q05901 1/20 0.48
KMT2A Q03164 2/20 0.46
APP P05067 4/20 0.39
CYP11B2 P19099 2/20 0.39
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 1/20 0.36
RECQL P46063 1/20 0.36
ADRA2A P08913 1/20 0.36
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1605849 0.84 KMT2A (0.49) CHRNB1CHRNB2CHRNB4CHRNA3CHRNB3
SCHEMBL1605850 0.84 KMT2A (0.49) CHRNB1CHRNB2CHRNB4CHRNA3CHRNB3
SCHEMBL1605519 0.79 KMT2A (0.54) CHRNB1CHRNB2CHRNB4CHRNA3CHRNB3
SCHEMBL1605789 0.75 CHRNB1 (0.58) CHRNB1CHRNB2CHRNB4CHRNA3CHRNB3
SCHEMBL1606261 0.75 CHRNB1 (0.51) CHRNB1CHRNB2CHRNB4CHRNA3CHRNB3
SCHEMBL1605878 0.72 KMT2A (0.55) CHRNB1CHRNB2CHRNB4CHRNA3CHRNB3
SCHEMBL16196639 0.72 KMT2A (0.58) CHRNB1CHRNB2CHRNB4CHRNA3CHRNB3
SCHEMBL1605168 0.72 KMT2A (0.58) CHRNB1CHRNB2CHRNB4CHRNA3CHRNB3
SCHEMBL1605248 0.72 KMT2A (0.58) CHRNB1CHRNB2CHRNB4CHRNA3CHRNB3
SCHEMBL1605979 0.72 KMT2A (0.58) CHRNB1CHRNB2CHRNB4CHRNA3CHRNB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009156462-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-12-30 WO disclosed